April 29th 2025
A pre-clinical study shows the antibiotic, piperacillin, was effective at much lower dosages than doxycycline, and did so without disrupting the gut microbiome.
Updated Surviving Sepsis Campaign Guidelines Not Endorsed by IDSA
December 18th 2017The Infectious Diseases Society of America’s (IDSA) decision not to endorse the 2016 Surviving Sepsis Campaign Guidelines comes from disagreement on the diagnosis and management of the microbial etiology of the disease.
Read More